Hexahistidine-metal assemblies: A promising drug delivery system

Huang, Wenjuan; Hao, Pengyan; Qin, Jianghui; Luo, Shijian; Zhang, Tinghong; Peng, Bo; Chen, Hao; Zan, Xingjie

doi:10.1016/j.actbio.2019.03.058

Cited by 32 publications

(69 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The SEM images show a network-like nanostructure of the peptide ( Figure 2A ). Similar structures were previously received from a hexahistidine peptide’s assembly with Zn ions ( Huang et al, 2019 ). The structure does not differ greatly with the addition of Cu ions but appears rougher after the reduction treatment with NaBH 4 .…”

Section: Resultsmentioning

confidence: 85%

“…We measured CaF 2 plates coated with the peptide, a mixture of the peptide and CuCl 2 , and a mixture of the peptide, CuCl 2 , and NaBH 4 . The broad peak at 1,600 cm −1 and the narrower one at 1,606 cm −1 for the PC-and PCN-coated surfaces respectively, could be attributed to the degree of crystallinity of the structures on the plate ( Huang et al, 2019 ). This could be explained due to the formation of Cu crystals on the PC-and PCN-coated plates and is supported by the XPS results, which show a majority of reduced Cu atoms also on the PC-coated surface ( Figure 3B ).…”

Section: Resultsmentioning

confidence: 99%

“…Since most COVID-19 infections appear to be transmitted through aerosols, applying this coating on air filters could be advantageous. Additionally, the possibility of using this peptide for purposes of drug delivery combined with the pH-dependent release potential of hexahistidine is intriguing ( Huang et al, 2019 ; Zhang et al, 2020 ). At times when there are wide-spread epidemics or pandemics caused by viruses, such as influenza virus or coronavirus, an antiviral and antimicrobial coating like the one presented here could provide valuable means to combat the spread of the disease, prevent bacterial infections of immunodeficient patients in hospitals, and to recover faster from the state of emergency.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

A Novel Copper-Binding Peptide That Self-Assembles Into a Transparent Antibacterial and Antiviral Coating

Boas

Reches

2021

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

The health, economy, and quality of life all over the world are greatly affected by bacterial infections and viral outbreaks. Bacterial cells and viruses, such as influenza, can spread through contaminated surfaces and fomites. Therefore, a possible way to fight these pathogens is to utilize antibacterial and antiviral coatings, which reduce their numbers on contaminated surfaces. Here, we present a novel short peptide that can self-assemble, adhere to various surfaces, and bind different metal ions such as copper, which provides the surface with antibacterial and antiviral properties. For these functions, the peptide incorporates the amino acid 3,4-dihydroxyphenylalanine (DOPA), which provides the peptide with adhesive capabilities; a diphenylalanine motif that induces the self-assembly of the peptide; the metal-binding hexahistidine sequence. Our results demonstrate that the coating, which releases monovalent cuprous ions and hydrogen peroxide, provides the surfaces with significant antibacterial and antiviral properties. Additionally, the coating remains transparent, which is favorable for many objects and especially for display screens.

show abstract

Section: Resultsmentioning

confidence: 85%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A Novel Copper-Binding Peptide That Self-Assembles Into a Transparent Antibacterial and Antiviral Coating

Boas

Reches

2021

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

show abstract

“…The synthesis of HmA@Ava was conducted by following the drug encapsulation procedure for HmA [ 34 ]. In brief, 10 μL of Zn(NO 3 ) 2 ·6H 2 O (30 mg/mL) was added dropwise to a 200 μL solution containing Ava, His 6 (0.84 mg), and polyvinyl pyrrolidone (1 mg) and buffered with 50 mM HEPES at a pH of 8.0.…”

Section: Methodsmentioning

confidence: 99%

“…The Ava encapsulation efficiency (EE%) and loading capacity (LCwt%) were calculated as per previously reported equations [ 34 ].

and

represent the UV– vis absorbance of the original and supernatant solutions of Ava, respectively;

and

are the volume of the original and supernatant solutions, respectively, and

and

are the weight of the added Ava and added His 6 , respectively.…”

Section: Methodsmentioning

confidence: 99%

Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model

Tang

Huang

et al. 2021

Materials Today Bio

View full text Add to dashboard Cite

Because of their high specificity and low side effects, protein drugs possess a substantial global market. However, the low bioavailability of protein is still a major obstacle to their expanded applications, which is expected to be answered with proper protein formulations. Taking corneal neovascularization (CNV) as an example, we demonstrated a co-assembled system of hexa-histidine and Ava (Avastin) with metal ions (HmA@Ava) could cross the cornea, the most important bio-barrier during the treatment of most diseases of the anterior segment in clinics. We found that the nanosized HmA@Ava efficiently encapsulated Ava with impressive loading capacity without destroying the bioactivity of Ava and assisted Ava penetration through the corneal barriers to effectively inhibit CNV development in an alkali burn rat model with sustained and pH-dependent Ava release. Our results suggested that the co-assembled strategy of protein and HmA is a proper formulation to protein drugs, with promising penetration ability to deliver protein across bio-barriers, which could open a path for topical administration of protein drugs for treatment of various ocular diseases and hold enormous potential for delivery of therapeutic proteins not only for ocular diseases but also for other diseases that require protein treatment.

show abstract

pH‐Responsive Hexa‐Histidine Metal Assembly (HmA) with Enhanced Biocatalytic Cascades as the Vehicle for Glucose‐Mediated Long‐Acting Insulin Delivery

et al. 2023

Self Cite

View full text Add to dashboard Cite

Diabetes has been listed as one of the three major diseases that endanger human health. Accurately injecting insulin (Ins) depending on the level of blood glucose (LBG) is the standard treatment, especially controlling LBG in the long‐term by a single injection. Herein, the pH‐responsive hexa‐histidine metal assembly (HmA) encapsulated with enzymes (GOx and CAT) and Ins (HmA@GCI) is engineered as the vehicle for glucose‐mediated insulin delivery. HmA not only shows high proteins loading efficiency, but also well retained proteins activity and protect proteins from protease damage. Within HmA, the biocatalytic activities of enzymes and the efficiency of the cascade reaction between GOx and CAT are enhanced, leading to a super response to the change of LBG with insulin release and efficient clearance of harmful byproducts of GOx (H2O2). In the treatment of diabetic mice, HmA@GCI reduces LBG to normal in half an hour and maintains for more than 5 days by a single subcutaneous injection, and nearly 24 days with four consecutive injections. During the test period, no symptoms of hypoglycemia and toxicity to tissues and organs are observed. These results indicate that HmA@GCI is a safe and long‐acting hypoglycemic agent with prospective clinical application.

show abstract

Hexahistidine-metal assemblies: A promising drug delivery system

Cited by 32 publications

References 52 publications

A Novel Copper-Binding Peptide That Self-Assembles Into a Transparent Antibacterial and Antiviral Coating

A Novel Copper-Binding Peptide That Self-Assembles Into a Transparent Antibacterial and Antiviral Coating

Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model

pH‐Responsive Hexa‐Histidine Metal Assembly (HmA) with Enhanced Biocatalytic Cascades as the Vehicle for Glucose‐Mediated Long‐Acting Insulin Delivery

Contact Info

Product

Resources

About